[ Price : $8.95]
Enlivex Therapeutics reports mixed results from its Phase 2 study of Allocetra in patients with sepsis.[ Price : $8.95]
FDA grants PureTech Health a fast-track designation for LYT-200 in combination with anti-PD1 therapy for treating recurrent/metast...[ Price : $8.95]
FDA grants 16 Bit Inc. a de novo marketing authorization for Rho, an AI-enabled software device aimed at improving osteoporosis sc...[ Price : $8.95]
As FDA continues to evaluate the risk of suicidal thoughts or actions in patients taking glucagon-like peptide-1 receptor agonists...[ Price : $8.95]
FDA approves new safety labeling for Veloxis Pharmaceuticals Envarsus XR (tacrolimus), indicated for use with other medicines to h...[ Price : $8.95]
Fresenius Kabi USA recalls (Class 1) its large-volume pump software of the Ivenix Infusion System due to software anomalies that h...[ Price : $8.95]
FDA classifies a December inspection at Sun Pharmaceutical Industries Dadra, India facility as official action indicated.[ Price : $8.95]
FDAs Oncologic Drugs Advisory Committee unanimously votes (12 to 0) that the totality of data are adequate to support the use of m...